Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenergic alpha-1D receptor (ADRA1D) is a key regulator of vascular tone via sympathetic-mediated vasoconstriction. It acts mainly through calcium-dependent pathways following activation by endogenous catecholamines such as norepinephrine. Its predominant expression on blood vessels makes it an attractive target for research into cardiovascular diseases like hypertension.
Activation of Gq/11 proteins, leading to stimulation of phospholipase C and increased intracellular calcium influx.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenergic Alpha-1D Receptor (ADRA1D).